Biocept (BIOC) Financials

$12.4 M

Mkt cap, 21-May-2018

$806.9 K

Revenue Q1, 2018
Gross profit (Q1, 2018)-1.6 M
Gross profit margin (Q1, 2018), %(201.7%)
EBIT (Q1, 2018)-6.3 M
Cash, 31-Mar-20189.3 M

Revenue/Financials

Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

5.1 m

Cost of goods sold

9.3 m

Gross profit

(4.3 m)

Gross profit Margin, %

(84%)

Sales and marketing expense

6.3 m

R&D expense

3.4 m

General and administrative expense

7.2 m

Operating expense total

26.2 m

EBIT

(21.2 m)

EBIT margin, %

(418%)

Interest expense

482.6 k

Pre tax profit

(21.6 m)

Income tax expense

(7.6 k)

Net Income

(15.9 m)(16.9 m)(18.4 m)

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

76.8 k164.9 k221.4 k662.9 k1 m1.7 m1.3 m806.9 k

Cost of goods sold

985.2 k1.2 m1.5 m1.7 m1.9 m2.1 m2.4 m2.4 m

Gross profit

(908.5 k)(994.9 k)(1.3 m)(1 m)(829 k)(446.4 k)(1.1 m)(1.6 m)

Gross profit Margin, %

(1183%)(603%)(566%)(152%)(79%)(27%)(85%)(202%)

Sales and marketing expense

851.1 k1.1 m1.3 m1.3 m1.3 m1.3 m1.7 m1.6 m

R&D expense

772.1 k677.7 k728.1 k716.3 k600.6 k757.3 k842 k1.1 m

General and administrative expense

1.4 m1.6 m1.5 m1.5 m1.9 m1.9 m1.8 m1.9 m

Operating expense total

3 m4.5 m5 m5.2 m5.7 m6.1 m6.8 m7.1 m

EBIT

(3.9 m)(4.4 m)(4.8 m)(4.5 m)(4.6 m)(4.4 m)(5.5 m)(6.3 m)

EBIT margin, %

(5068%)(2644%)(2156%)(684%)(442%)(261%)(428%)(777%)

Interest expense

169 k176.1 k138.4 k99.7 k154.9 k82.5 k214.4 k82.7 k

Pre tax profit

(4 m)(4.5 m)(4.9 m)(4.6 m)(4.7 m)(4.4 m)(5.7 m)(6.4 m)

Income tax expense

(355 )(199 )(1.6 k)(503 )(199 )(1.6 k)(2.1 k)

Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

5.4 m8.8 m4.6 m2.1 m

Accounts Receivable

10.6 k34.2 k129 k1.2 m

Inventories

338.7 k435.9 k484.6 k498.7 k

Current Assets

5.9 m9.6 m5.8 m4.3 m

PP&E

3.1 m

Total Assets

6.6 m10.6 m7.6 m7.4 m

Accounts Payable

641.4 k632.5 k960.5 k1.3 m

Current Liabilities

1.4 m3.3 m4.4 m4.7 m

Long-term debt

5.2 m

Total Liabilities

6.9 m6.1 m

Additional Paid-in Capital

138.1 m158.9 m174.3 m196.5 m

Retained Earnings

(138.3 m)(155.2 m)(173.6 m)(195.2 m)

Total Equity

658.7 k1.3 m

Financial Leverage

11.5 x5.7 x

Quarterly

USDQ3, 2017Q1, 2018

Cash

9.3 m

Accounts Receivable

1.3 m

Inventories

412.9 k491 k

Current Assets

11.8 m

PP&E

3 m

Total Assets

14.7 m

Accounts Payable

1.6 m1.4 m

Current Liabilities

4.9 m

Total Liabilities

6.2 m

Additional Paid-in Capital

210.1 m

Retained Earnings

(201.6 m)

Total Equity

8.5 m

Financial Leverage

1.7 x

Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(15.9 m)(16.9 m)(18.4 m)(21.6 m)

Depreciation and Amortization

251.2 k261.4 k322 k575.7 k

Accounts Receivable

(1.4 k)(23.6 k)(94.8 k)(1.1 m)

Inventories

(401.4 k)(80.4 k)494.7 k100.9 k

Accounts Payable

(981.9 k)(51.8 k)332.7 k349.9 k

Cash From Operating Activities

(14.6 m)(15.2 m)(15.7 m)(19.7 m)

Cash From Investing Activities

(394.9 k)(165.2 k)(451.4 k)(1.4 m)

Cash From Financing Activities

20.3 m18.8 m11.9 m18.6 m

Interest Paid

402.1 k405.7 k358.6 k358.5 k

Income Taxes Paid

800 2.2 k2.1 k5.3 k

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Accounts Receivable

15.6 k32.1 k40.4 k43.4 k86.7 k85.7 k834.9 k994.7 k

Inventories

412.9 k

Accounts Payable

970.5 k612.5 k766.4 k853.3 k946.3 k1.7 m1.4 m1.8 m1.6 m

Ratios

USDY, 2018

Financial Leverage

1.7 x
Report incorrect company information